FDA NDC Directory · JSON-LD · Markdown

Everolimus

NDC 70377-092 · HUMAN PRESCRIPTION DRUG · TABLET, FOR SUSPENSION

Labeler / ManufacturerBiocon Pharma Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA217216
Dosage form / routeTABLET, FOR SUSPENSION · ORAL
Active ingredientsEVEROLIMUS (5 mg/1)
Marketing started20260114
Package count2

External sources

Source: openFDA. Public-domain (CC0).